Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Biliary Tract Neoplasms × aflibercept × Clear all

Sponsor

Conditions

Neoplasm Metastasis 9 Colorectal Neoplasms 7 Rectal Neoplasms 5 Colorectal Cancer Metastatic 5 Ovarian Neoplasms 3 Neoplasms 3 Lung Neoplasms 3 Colonic Neoplasms 3 Uveal Melanoma 2 Melanoma 2 Fallopian Tube Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma 2 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Stomach Neoplasms 1 Somatostatinoma 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neurofibromatosis 2 1 Myeloproliferative Disorders 1 Multiple Endocrine Neoplasia Type 1 1 Macular Degeneration 1 Lung Diseases 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Fibrolamellar hepatocellular carcinoma 1

Interventions

Gemcitabine 14 Cisplatin 10 Nivolumab 6 pembrolizumab 4 Oxaliplatin 4 Capecitabine 4 trametinib 3 tremelimumab 2 lenvatinib 2 durvalumab 2 derazantinib 2 atezolizumab 2 Ramucirumab 2 Radiofrequency Ablation 2 Fluorouracil 2 Cryosurgery 2 Bevacizumab 2 zanidatamab 1 vandetanib 1 tocilizumab 1 telotristat ethyl 1 sargramostim 1 rucaparib 1 regorafenib 1 pertuzumab 1 merestinib 1 irinotecan sucrosofate 1 devimistat 1 dabrafenib 1 cytokine inducible SH2-containing protein 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡